PATENT CLAIM ANALYSIS

Application Number: 15952792
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["435", "006000"]

Abstract:
The present invention provides compositions and methods based on genetic polymorphisms that are associated with response to statin treatment, particularly for reducing the risk of cardiovascular disease, especially coronary heart disease (such as myocardial infarction) and stroke. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents and kits for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents and kits for their detection.

Claim (Index 26):
The method of  claim 1 , further comprising administering an HMG-CoA reductase inhibitor to said human who has said allele.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 91.0
- Lexical Diversity: 1.74576
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15150636', '12500378', '12569475', '15409162', '12077935']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5925774445363632
- 35 USC 102 Novelty (BERT): 0.529529255745527
- Combined Prediction Score: 0.5862726256572796
- Mean Citation Score: 320.595812
- Max Citation Score: 353.64047
- Similarity Product: 312.19957645320886

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test